CYP27A1 and breast carcinoma: In this regard, our investigation on CT-X antigen AKAP4 revealed that AKAP4 was immunogenic and generated humoral response in majority of breast cancer patients, as compared to healthy donors (P<0.001, Pearson’s Chi-square test).